The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen

Ciltacabtagene autoleucel vs standard of care in patients with functional high-risk multiple myeloma: CARTITUDE-4 subgroup analysis.
 
Luciano J. Costa
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi
Speakers' Bureau - Amgen; Sanofi
Research Funding - Amgen; Bristol-Myers Squibb/Celgene/Juno; Caribou Biosciences (Inst); Janssen
 
Katja C Weisel
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Menarini; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Menarini; Oncopeptides; Roche; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Menarini; Takeda
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); MERCK (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Surbhi Sidana
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Magenta Therapeutics; Oncopeptides; Sanofi
Research Funding - Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Magenta Therapeutics (Inst)
 
Yaël C Cohen
Honoraria - Bristol-Myers Squibb; Janssen; Roche
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen
Speakers' Bureau - Abbvie; GlaxoSmithKline
Research Funding - Takeda
Travel, Accommodations, Expenses - Sanofi Aventis GmbH
 
Duncan Purtill
Research Funding - Atara Biotherapeutics; Janssen; Novartis; Takeda
 
Cyrille Touzeau
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Takeda
Research Funding - Sanofi (Inst)
 
Carlos Fernandez de Larrea
Honoraria - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer
Consulting or Advisory Role - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer
 
Joaquin Martinez-Lopez
Consulting or Advisory Role - BMS, Janssen, Roche, Novartis, Gilead, Astellas, Pfizer, Menarini
Speakers' Bureau - BMS, Janssen, Roche, Novartis, Gilead, Astellas,
Research Funding - BMS, Astellas, Janssen
Travel, Accommodations, Expenses - BMS, Janssen, Roche, Novartis, Gilead, Pfizer,
 
Nikoletta Lendvai
No Relationships to Disclose
 
Ana Slaughter
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Patents, Royalties, Other Intellectual Property - Johnson & Johnson/Janssen
 
Carolina Lonardi
Employment - Johnson & Johnson/Janssen
Leadership - Johnson & Johnson/Janssen (I)
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Man Zhao
Employment - Haisco Pharmaceutical (I); IQVIA; Janssen
Research Funding - Haisco Pharmaceutical (I)
Patents, Royalties, Other Intellectual Property - Haisco Pharmaceutical (I)
 
Katherine Li
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Martin Vogel
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Mythili Koneru
Employment - Legend Biotech
Leadership - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Nitin Patel
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Erika Florendo
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
Research Funding - Legend Biotech
Travel, Accommodations, Expenses - Legend Biotech
 
Octavio Costa Filho
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda